|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/09/17 Mentor Capital, Inc. 10-Q 9/30/17 103:6.7M Action Edgar Fil… Svc/FA |
Document/Exhibit Description Pages Size
1: 10-Q Form 10-Q Quarterly Report HTML 443K
2: EX-4.3 Exhibit 4.3 Certificate of Designation - Series Q HTML 34K
3: EX-31.1 Exhibit 31.1 Section 302 Certification HTML 40K
4: EX-31.2 Exhibit 31.2 Section 302 Certification HTML 41K
5: EX-32.1 Exhibit 32.1 Section 906 Certification HTML 36K
6: EX-32.2 Exhibit 32.2 Section 906 Certification HTML 36K
13: R1 Document and Entity Information HTML 75K
14: R2 Condensed Consolidated Balance Sheets, (September HTML 157K
30, 2017 Unaudited)
15: R3 Condensed Consolidated Balance Sheets, (September HTML 53K
30, 2017 Unaudited) - Parenthetical
16: R4 Condensed Consolidated Income Statements HTML 92K
(Unaudited)
17: R5 Condensed Consolidated Statement of Comprehensive HTML 49K
Income (Unaudited)
18: R6 Condensed Consolidated Statements of Cash Flows HTML 153K
(Unaudited)
19: R7 Note 1 - Nature Of Operations HTML 46K
20: R8 Note 2 - Summary of significant accounting HTML 63K
policies
21: R9 Note 4- Prepaid expenses and other assets HTML 41K
22: R10 Note 5 - Bhang Corporation (formerly known as HTML 46K
Bhang Chocolate Company, Inc.) and Judgment
23: R11 Note 6 - Investment in account receivable HTML 47K
24: R12 Note 7 - Property and Equipment HTML 45K
25: R13 Note 8 - Convertible notes receivable HTML 56K
26: R14 Note 9 - Note purchase agreement and consulting HTML 47K
agreement with G FarmaLabs Limited
27: R15 Note 10 - Contractual interest in legal recovery HTML 38K
28: R16 Note 11- Investments and Fair Value HTML 87K
29: R17 Note 12 - Common stock warrants HTML 59K
30: R18 Note 13- Warrant redemption liability HTML 42K
31: R19 Note 14 - Stockholders' Equity HTML 42K
32: R20 Note 15 - Lease Commitments HTML 45K
33: R21 Note 16 - Long Term Debt HTML 48K
34: R22 Note 17 - Accrued salary, accrued retirement and HTML 45K
incentive fee - related party
35: R23 Note 18 - Patent and License Fee Facility with HTML 37K
Larson
36: R24 Note 19 - Commitments and Contingencies HTML 41K
37: R25 Note 20 - Segment Information HTML 94K
38: R26 Note 21 - Accumulated other comprehensive income HTML 53K
(Loss)
39: R27 Note 22 - Subsequent Events HTML 37K
40: R28 Note 1 - Nature Of Operations: Condensed HTML 37K
consolidated financial statements (Policies)
41: R29 Note 2 - Summary of significant accounting HTML 37K
policies: Basis of presentation (Policies)
42: R30 Note 2 - Summary of significant accounting HTML 38K
policies: Concentrations of cash (Policies)
43: R31 Note 2 - Summary of significant accounting HTML 39K
policies: Policy 4 - Cash and Cash Equivalents
(Policies)
44: R32 Note 2 - Summary of significant accounting HTML 39K
policies: Cash in attorney trust account
(Policies)
45: R33 Note 2 - Summary of significant accounting HTML 40K
policies: Policy 5 - Accounts Receivable
(Policies)
46: R34 Note 2 - Summary of significant accounting HTML 44K
policies: Convertible notes receivable (Policies)
47: R35 Note 2 - Summary of significant accounting HTML 40K
policies: Policy 7 - Investments (Policies)
48: R36 Note 2 - Summary of significant accounting HTML 38K
policies: Investment in account receivable, net of
discount (Policies)
49: R37 Note 2 - Summary of significant accounting HTML 37K
policies: Policy 9 - Notes Receivable (Policies)
50: R38 Note 2 - Summary of significant accounting HTML 38K
policies: Policy 10 - Property, equipment and
machinery (Policies)
51: R39 Note 2 - Summary of significant accounting HTML 39K
policies: Policy 11 - Goodwill (Policies)
52: R40 Note 2 - Summary of significant accounting HTML 39K
policies: Policy 12 - Revenue Recognition
(Policies)
53: R41 Note 2 - Summary of significant accounting HTML 38K
policies: Policy 13 - Basic and diluted income
(Loss) Per Common Share (Policies)
54: R42 Note 2 - Summary of significant accounting HTML 41K
policies: Policy 14 - Income Taxes (Policies)
55: R43 Note 2 - Summary of significant accounting HTML 38K
policies: Policy 15 - Advertising and Promotion
(Policies)
56: R44 Note 2 - Summary of significant accounting HTML 38K
policies: Policy 16 - Use of Estimates (Policies)
57: R45 Note 2 - Summary of significant accounting HTML 40K
policies: Policy 17 - Fair Value Measurements
(Policies)
58: R46 Note 2 - Summary of significant accounting HTML 37K
policies: Recent Accounting Standards (Policies)
59: R47 Note 4- Prepaid expenses and other assets: HTML 40K
Schedule of Prepaid expenses and other assets
(Tables)
60: R48 Note 5 - Bhang Corporation (formerly known as HTML 43K
Bhang Chocolate Company, Inc.) and Judgment:
Schedule of Receivable and Accrued Interest
(Tables)
61: R49 Note 6 - Investment in account receivable: HTML 44K
Schedule of Receivables with Imputed Interest
(Tables)
62: R50 Note 7 - Property and Equipment: Property, Plant HTML 45K
and Equipment (Tables)
63: R51 Note 8 - Convertible notes receivable: Schedule of HTML 53K
Convertible Notes Receivable (Tables)
64: R52 Note 9 - Note purchase agreement and consulting HTML 40K
agreement with G FarmaLabs Limited: Schedule of
Notes receivable from G Farma (Tables)
65: R53 Note 11- Investments and Fair Value: Schedule of HTML 70K
hierarchy of Level 1, Level 2 and Level 3 Assets
(Tables)
66: R54 Note 11- Investments and Fair Value: Schedule of HTML 43K
amortized costs, gross unrealized holding gains
and losses, and fair values of Available-for-sale
Securities (Tables)
67: R55 Note 11- Investments and Fair Value: Schedule of HTML 45K
unrealized gains and losses on Available-for-sale
Securities held at the reporting date (Tables)
68: R56 Note 12 - Common stock warrants: Schedule of HTML 46K
Series B and Series D common stock warrants
(Tables)
69: R57 Note 12 - Common stock warrants: Schedule of HTML 41K
Series E, F, G and H warrants (Tables)
70: R58 Note 15 - Lease Commitments: Schedule of HTML 40K
approximate remaining annual minimum lease
payments (Tables)
71: R59 Note 16 - Long Term Debt: Schedule of Long term HTML 48K
debt and revolving line of credit (Tables)
72: R60 Note 17 - Accrued salary, accrued retirement and HTML 42K
incentive fee - related party: Schedule of
Outstanding Liability (Tables)
73: R61 Note 20 - Segment Information: Schedule of Segment HTML 77K
Information (Tables)
74: R62 Note 20 - Segment Information: Reconciliation of HTML 50K
Revenue from Segments to Consolidated (Tables)
75: R63 Note 21 - Accumulated other comprehensive income HTML 53K
(loss): Schedule of Long term debt and revolving
line of credit (Tables)
76: R64 Note 1 - Nature Of Operations (Details) HTML 36K
77: R65 Note 2 - Summary of significant accounting HTML 36K
policies: Policy 11 - Goodwill (Details)
78: R66 Note 2 - Summary of significant accounting HTML 36K
policies: Policy 13 - Basic and diluted income
(Loss) Per Common Share (Details)
79: R67 Note 2 - Summary of significant accounting HTML 37K
policies: Policy 15 - Advertising and Promotion
(Details)
80: R68 Note 4- Prepaid expenses and other assets: HTML 43K
Schedule of Prepaid expenses and other assets
(Details)
81: R69 Note 5 - Bhang Corporation (formerly known as HTML 43K
Bhang Chocolate Company, Inc.) and Judgment:
Schedule of Receivable and Accrued Interest
(Details)
82: R70 Note 6 - Investment in account receivable: HTML 43K
Schedule of Receivables with Imputed Interest
(Details)
83: R71 Note 6 - Investment in account receivable HTML 36K
(Details)
84: R72 Note 7 - Property and Equipment: Property, Plant HTML 48K
and Equipment (Details)
85: R73 Note 8 - Convertible notes receivable: Schedule of HTML 48K
Convertible Notes Receivable (Details)
86: R74 Note 9 - Note purchase agreement and consulting HTML 41K
agreement with G FarmaLabs Limited: Schedule of
Notes receivable from G Farma (Details)
87: R75 Note 11- Investments and Fair Value: Schedule of HTML 56K
hierarchy of Level 1, Level 2 and Level 3 Assets
(Details)
88: R76 Note 11- Investments and Fair Value: Schedule of HTML 44K
amortized costs, gross unrealized holding gains
and losses, and fair values of Available-for-sale
Securities (Details)
89: R77 Note 11- Investments and Fair Value: Schedule of HTML 43K
unrealized gains and losses on Available-for-sale
Securities held at the reporting date (Details)
90: R78 Note 12 - Common stock warrants (Details) HTML 44K
91: R79 Note 12 - Common stock warrants: Schedule of HTML 45K
Series B and Series D common stock warrants
(Details)
92: R80 Note 12 - Common stock warrants: Schedule of HTML 39K
Series E, F, G and H warrants (Details)
93: R81 Note 14 - Stockholders' Equity (Details) HTML 43K
94: R82 Note 15 - Lease Commitments: Schedule of HTML 48K
approximate remaining annual minimum lease
payments (Details)
95: R83 Note 16 - Long Term Debt: Schedule of Long term HTML 43K
debt and revolving line of credit (Details)
96: R84 Note 17 - Accrued salary, accrued retirement and HTML 43K
incentive fee - related party: Schedule of
Outstanding Liability (Details)
97: R85 Note 20 - Segment Information: Schedule of Segment HTML 67K
Information (Details)
98: R86 Note 20 - Segment Information: Reconciliation of HTML 48K
Revenue from Segments to Consolidated (Details)
99: R87 Note 21 - Accumulated other comprehensive income HTML 56K
(loss): Schedule of Long term debt and revolving
line of credit (Details)
100: R88 Note 22 - Subsequent Events (Details) HTML 40K
102: XML IDEA XML File -- Filing Summary XML 207K
101: EXCEL IDEA Workbook of Financial Reports XLSX 91K
9: EX-101.INS XBRL Instance -- mntr-20170930 XML 975K
7: EX-101.CAL XBRL Calculations -- mntr-20170930_cal XML 189K
8: EX-101.DEF XBRL Definitions -- mntr-20170930_def XML 185K
10: EX-101.LAB XBRL Labels -- mntr-20170930_lab XML 654K
11: EX-101.PRE XBRL Presentations -- mntr-20170930_pre XML 553K
12: EX-101.SCH XBRL Schema -- mntr-20170930 XSD 198K
103: ZIP XBRL Zipped Folder -- 0001078782-17-001521-xbrl Zip 94K
| Exhibit 4.3 Certificate of Designation - Series Q |
